Beaird Harris Wealth Management’s Revolution Medicines RVMD Stock Holding History

Beaird Harris Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.68K	Hold	41	–	–	﹤0.01%	414
2026 Q1	$3.99K	Hold	41	–	–	﹤0.01%	436
2025 Q4	$3.27K	Hold	41	–	–	﹤0.01%	481
2025 Q3	$1.92K	Hold	41	–	–	﹤0.01%	514
2025 Q2	$1.51K	Hold	41	–	–	﹤0.01%	524
2025 Q1	$1.45K	Hold	41	–	–	﹤0.01%	470
2024 Q4	$1.79K	Hold	41	–	–	﹤0.01%	449
2024 Q3	$1.86K	Hold	41	–	–	﹤0.01%	447
2024 Q2	$1.59K	Hold	41	–	–	﹤0.01%	559
2024 Q1	$1.32K	Hold	41	–	–	﹤0.01%	519
2023 Q4	$1.18K	Hold	41	–	–	﹤0.01%	510
2023 Q3	$1.14K	Hold	41	–	–	﹤0.01%	389
2023 Q2	$1.1K	Hold	41	–	–	﹤0.01%	391
2023 Q1	$889	Hold	41	–	–	﹤0.01%	417
2022 Q4	$977	Sell	41 -41	-50%	-$872	﹤0.01%	640
2022 Q3	$2K	Hold	82	–	–	﹤0.01%	409
2022 Q2	$2K	Hold	82	–	–	﹤0.01%	347
2022 Q1	$2K	Hold	82	–	–	﹤0.01%	530
2021 Q4	$2K	Buy	+82	New	+$2.31K	﹤0.01%	575

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Beaird Harris Wealth Management's RVMD Position: Q2 2026 in Review

Beaird Harris Wealth Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 41 shares worth $7.68K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

Beaird Harris Wealth Management first reported a position in RVMD in Q4 2021 and has held it in 19 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Beaird Harris Wealth Management held 41 shares of Revolution Medicines worth $7.68K as of Q2 2026.
Beaird Harris Wealth Management left its Revolution Medicines share count unchanged in Q2 2026.
Revolution Medicines made up ﹤0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #414 holding.
Beaird Harris Wealth Management first reported a position in Revolution Medicines in Q4 2021 and has held it in 19 quarters since.
691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.